Inform, Empower, Connect

Result

Age
Country
City
Trial Status
I am interested in
Trial Phase
Clinicaltrial.gov ID/ NCT Number
Keyword
Trial Name Status Phase Country City
Larotrectinib in Treating Patients With Previously Untreated TRK Fusion Solid Tumors and TRK Fusion Relapsed Acute Leukemia

The aim of this trial is to test the side effects of a drug called larotrectinib in people with previously untreated TRK gene fusion solid tumors. This trial is for several types of cancer. People wit...

Active, not recruiting Phase 2, United States, Canada, Birmingham, Little Rock, Downey, Los Angeles, Oakland, Orange, San Francisco, Aurora, Denver, New Haven, Wilmington, Washington, Fort Lauderdale, Fort Myers, Gainesville, Jacksonville, ...
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors

The aim of this trial is to test the safety and response to a drug called metarrestin in people with cancer that has spread. This trial is for several types of cancer. People with osteosarcoma may be ...

Recruiting Phase 1, United States, Fairway, Bethesda,
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

The aim of this trial is to test licenced drugs in cancers that are not responding to treatment. The drugs tested will depend on the genetics of the cancer. Certain genetic changes are more sensitive ...

Recruiting Phase 2, United States, Birmingham, Phoenix, Auburn, Berkeley, Los Angeles, Oakland, Palo Alto, Roseville, Sacramento, San Francisco, San Jose, San Leandro, Santa Clara, Santa Cruz, Sunnyvale, Vallejo, Walnut...
Tumor-Agnostic Precision Immuno-Oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study

The aim of this trial is to test different drugs on cancers with specific genetic mutations. The trial will assess how effective the drugs are at treating the cancer. Participants will be assigned to ...

Recruiting Phase 2, United States, Australia, Belgium, Brazil, Canada, China, Denmark, France, Germany, Hong Kong, Israel, Italy, Japan, Korea, Republic of, Netherlands, New Zealand, Poland, Portugal, ... Daphne, Goodyear, Duarte, Los Angeles, Newport Beach, Sacramento, San Francisco, Santa Monica, Newark, Gainesville, Miami, Ocala, Athens, Boise, Zion, Lafayette, Scarborough, Silver S...
A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors

The aim of this trial is to test the safety and side effects of a drug called HFB200301 in people with advanced cancer. This trial is for several types of cancer. People with osteosarcoma may be able ...

Recruiting Phase 1, United States, Spain, Scottsdale, Los Angeles, Jacksonville, Rochester, Saint Louis, Houston, Fairfax, Barcelona, Madrid, Valencia,
Quality Improvement Project - "My Logbook! - I Know my Way Around!"; ("Mein Logbuch - Ich Kenne Mich Aus!")

The aim of this trial is to implement and evaluate the use of educational booklets for children during their cancer journey. The aim is to improve the well-being and mental health of childhood cancer ...

Recruiting Not Applicable, Austria, Germany, Italy, Switzerland, Linz, St. Veit, Graz, Salzburg, Vienna, Nürnberg, Frankfurt am Main, Hannover, Essen, Münster, Homburg, Leipzig, Bad Oeynhausen, Berlin, Bielefeld, Cologne, Dresden, Erlangen, Hamb...
Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors

The aim of this trial is to test the side effects and best dose of natural killer cells in combination with the chemotherapy drugs cyclophosphamide and etoposide. They are testing this in several type...

Recruiting Phase 1, United States, Houston,
Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid Tumors

This phase I trial is studying the side effects and best dose of erlotinib when given with temozolomide in treating young patients with recurrent or refractory solid tumors. Erlotinib may stop the gro...

Completed Phase 1, United States, Arcadia,
cfMeDIP-seq Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

This trial aims to collect genetic data from cancers to see if it can be used to detect cancer and identify any cancer left after treatment. It will be compared with data from non-cancer patients. Th...

Recruiting United States, Duarte, Rochester, Cleveland, Portland, Memphis, Nashville, Austin,
SPEARHEAD-3 Pediatric Study

The aim of this trial is to test the safety and effectiveness of the drug afamitresgene autoleucel in children and young people with MAGE-A4 positive cancer. This includes people with osteosarcoma. E...

Not yet recruiting Phase 1, Phase 2, United States, Palo Alto, Aurora, New York, Seattle,

Disclaimer

  • ONTEX is intended to supplement, not replace, your healthcare team. Patients should always discuss a clinical trial with their healthcare team. If a patient is eligible for a trial the trial team will be able to provide more in-depth information about the trial so the patient can make an informed decision before taking part. Trial information has been sourced from www.clinicaltrials.gov. The content is then reviewed weekly by the Osteosarcoma Now team. All the trials also have a patient-friendly summary and key information section written by the team at Osteosarcoma Now. We have also included a description of the medications being used in the trial and summarised the inclusion and exclusion criteria in the ‘who is this trial (not) for’ sections. To the best of our knowledge the clinical trial database is up-to-date and accurate.However, we cannot assume any liability for the accuracy or completeness of the information.